Pharmacy Daily | Telmisartan response

Other recent headlines

• 

  PD breaking news – Class action filed against Johnson & Johnson

  Friday | Dec 20 2024

  A Brisbane law firm has filed a class action against pharmaceutical giant Johnson & Johnson for…

  
• 

  AMA calls for more STI action

  Friday | Dec 20 2024

  THE Australian Medical Association (AMA) has welcomed the development of a national strategy on sexually transmissible infections, but says not enough is being done to tackle rising rates of sexually transmissible infections in vulnerable communities or to help eliminate congenital syphilis.

  
• 

  Leading care of period pain

  Friday | Dec 20 2024

  WITH new research finding that menstrual issues are often normalised or trivialised and undermanaged in young people, the study’s lead author says pharmacists are ideally placed to advise on pain management.